Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1985;7:734-741

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jespersen, L. T.
Right arrow Articles by Mulvany, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jespersen, L. T.
Right arrow Articles by Mulvany, M. J.

Hypertension, Vol 7, 734-741, Copyright © 1985 by American Heart Association


ARTICLES

Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats

LT Jespersen, NC Nyborg, OL Pedersen, EO Mikkelsen and MJ Mulvany

We have examined the effect of antihypertensive treatment on heart weight and on structural and functional characteristics of isolated mesenteric resistance vessels (internal diameter 170-220 micron) in spontaneously hypertensive rats (SHR) and in Wistar-Kyoto rats (WKY). The SHR and WKY were treated with hydralazine from the age of 4 weeks and were examined at ages 12 to 14 weeks and 23 to 27 weeks. Treated SHR had a mean blood pressure as much as 29% below that of control WKY, which in turn was 25 to 40% less than that of control SHR. In 12- to 14- week-old rats the heart to body weight ratio (which in control SHR was 13% greater than of WKY) was unaffected by treatment. Thereafter, the heart to body weight ratio of treated SHR did not increase as much as usual. At both ages, the media thickness and contractile response of the resistance vessels of the SHR (which were, respectively, 37% and 30% greater than those of vessels of WKY) were unaffected by treatment. However, because treatment caused a small (8%) increase in the lumen diameter of the vessels of the SHR, treatment did cause small, but possibly physiologically important, decreases both in the media to lumen ratio (11%) and in the pressure against which these vessels would have been able to contract (10%). Treatment had little effect on the pharmacological characteristics of vessels of either SHR or WKY. The results suggest that the increased heart weight, media thickness, and contractile response in mesenteric resistance vessels of SHR up to ages 23 to 27 weeks are due primarily to factors other than increased pressure.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
P.A. van Zwieten
The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy
Cardiovasc Res, January 1, 2000; 45(1): 82 - 91.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Masciotra, S. Picard, and C. F. Deschepper
Cosegregation Analysis in Genetic Crosses Suggests a Protective Role for Atrial Natriuretic Factor Against Ventricular Hypertrophy
Circ. Res., June 25, 1999; 84(12): 1453 - 1458.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. L. Baumbach
Effects of Increased Pulse Pressure on Cerebral Arterioles
Hypertension, February 1, 1996; 27(2): 159 - 167.
[Abstract] [Full Text]